• HyperFluor 488 Goat Anti-Human IgG Antibody: Workflow Innova

  2026-06-03

  The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody sets a new benchmark for sensitivity and versatility in translational immunoassays. Optimized for immunofluorescence, Western blotting, and flow cytometry, it delivers robust performance and actionable troubleshooting strategies for high-throughput vaccine research and immune monitoring.

• SIRT7 Mitigates hPDLF Aging and Inflammation via AKT/mTOR Su

  2026-06-02

  The referenced study demonstrates that SIRT7 overexpression reduces aging and inflammatory damage in human periodontal ligament fibroblasts (hPDLFs) by suppressing AKT/mTOR pathway activity. These findings illuminate new mechanistic links in periodontitis pathology and suggest targeted modulation of AKT/mTOR signaling as a promising research avenue for inflammatory and age-associated tissue degeneration.

• Epalrestat: Advanced Aldose Reductase Inhibitor Workflows

  2026-06-02

  Epalrestat stands out as a high-purity aldose reductase inhibitor, empowering precise modeling of diabetic complications and neurodegenerative diseases. This guide delivers actionable protocol enhancements and troubleshooting strategies for researchers seeking robust, reproducible results in oxidative stress and cancer metabolism studies.

• Bestatin Hydrochloride in Neurovascular and Tumor Research

  2026-06-01

  Explore how Bestatin hydrochloride (Ubenimex) advances neurovascular and tumor biology research. This article uniquely dissects its mechanistic impact on neuronal activity, angiogenesis, and research protocols, drawing on pivotal evidence and practical guidance.

• JZL184: A Strategic Catalyst for Translational Endocannabino

  2026-06-01

  Explore how the selective monoacylglycerol lipase inhibitor JZL184 is revolutionizing endocannabinoid signaling research, with a focus on mechanistic insights, experimental validation, and translational strategies relevant to pain, cognition, and neuronal protection. This article goes beyond typical product overviews, offering an actionable framework for researchers in neuropharmacology and beyond.

• Senolytic Effects of L. plantarum DS0037 ELNs in Cellular Ag

  2026-05-31

  This study demonstrates that exosome-like nanovesicles (ELNs) from Lactobacillus plantarum DS0037 selectively induce apoptosis in senescent cells, mimicking the action of established BCL-2 protein inhibitors. The findings highlight a novel, microbe-derived strategy for targeting cellular senescence, with implications for anti-aging and dermatological research.

• PP 3 in Advanced Src Kinase Pathway Analysis: Beyond Control

  2026-05-30

  Explore the vital role of 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine as a research use only chemical in dissecting Src kinase pathway specificity. This article offers a unique, in-depth perspective on optimizing assay design and interpretation using PP 3, with critical insights drawn from the latest vascular signaling research.

• Artesunate: Applied Protocols for Cancer Cell Death Research

  2026-05-29

  Artesunate, an artemisinin derivative, has redefined in vitro cancer research by enabling precise dissection of cell death mechanisms like ferroptosis and pyroptosis. This article delivers actionable workflows, protocol enhancements, and troubleshooting strategies tailored for oncology labs leveraging Artesunate’s unique mechanistic profile.

• InstaBlue Protein Stain Solution: Rapid Gel Visualization Gu

  2026-05-29

  InstaBlue Protein Stain Solution enables ultra-fast, sensitive detection of proteins in polyacrylamide gels, eliminating the need for fixation, washing, or hazardous solvents. It is best suited for workflows requiring high-throughput, mass spectrometry-compatible protein visualization. It should not be used in protocols that require traditional post-staining modifications involving methanol or acetic acid.

• PERK Loss Sensitizes Colorectal Cancer Cells to Ferroptosis

  2026-05-28

  This study demonstrates that inhibition of PERK, a key ER stress sensor, promotes ferroptosis in colorectal cancer by downregulating SLC7A11 (System Xc−). The findings clarify a mechanistic link between the unfolded protein response and ferroptotic vulnerability, providing actionable insights for researchers targeting apoptosis-resistant tumors.

• Pterostilbene Improves Mitochondrial Quality to Delay Fibrob

  2026-05-28

  Zhou et al. (2025) demonstrate that pterostilbene counteracts senescence in human dermal fibroblasts by enhancing mitochondrial quality, particularly through increased mitophagy. These findings clarify the mechanistic basis of dermal anti-aging interventions and suggest new strategies for preserving skin structure and function.

• PEtOx-Lipids as PEG Alternatives in mRNA LNP Delivery System

  2026-05-27

  This study systematically evaluates poly(2-ethyl-2-oxazoline) (PEtOx)-lipids as substitutes for poly(ethylene glycol) (PEG)-lipids in lipid nanoparticle (LNP) formulations for mRNA delivery. By tuning the polymer chain length, the authors demonstrate improved nanoparticle stability, reduced immunogenicity, and enhanced transfection efficacy—findings with direct relevance for gene therapy and mRNA-based research.

• AG-221 (Enasidenib) in IDH2-Mutant Leukemia: Workflows & Sol

  2026-05-27

  AG-221 (Enasidenib) empowers acute myeloid leukemia researchers to dissect and therapeutically target mutant IDH2-driven metabolic pathways. This guide offers advanced protocol parameters, troubleshooting strategies, and contextualizes the latest findings on metabolic rewiring and resistance, helping labs maximize the translational impact of AG-221 in IDH2-mutant hematologic malignancy studies.

• Nitric Oxide-Driven Nanomotors Enhance Glioblastoma Immunoth

  2026-05-26

  This study introduces a chemotactic nanomotor system targeting glioblastoma, leveraging tumor microenvironment cues to improve drug delivery and immune activation. The approach addresses persistent challenges in brain tumor immunotherapy, offering a multi-step strategy to enhance efficacy and prevent recurrence.

• Epalrestat and the Polyol Pathway: Beyond Diabetic Research

  2026-05-26

  Explore how Epalrestat, a potent aldose reductase inhibitor, is revolutionizing oxidative stress and cancer metabolism research through targeted polyol pathway inhibition. This in-depth article uncovers new mechanistic insights and practical protocols for advanced assay design.

7869 records 10/525 page Previous Next First page 上5页 678910 下5页 Last page